Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
2024 Mar;124:108531
You can reach our customer support team by email at [email protected]
manufacturing and testing dates
Pauses under 4 weeks usually allow resumption at the prior dose
Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
US$ 27.23
US$ 24.47
US$ 23.97
US$ 29.12
US$ 26.29
US$ 29.61
US$ 27.67
US$ 24.12
US$ 23.75
US$ 21.82
